Editorial : COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain. Authors' reply
| Errataetall: |
CommentOn: Aliment Pharmacol Ther. 2022 May;55(10):1244-1264. - PMID 35355306 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Alimentary pharmacology & therapeutics - 56(2022), 1 vom: 13. Juli, Seite 164-165 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bhurwal, Abhishek [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 Vaccines |
|---|
| Anmerkungen: |
Date Completed 14.06.2022 Date Revised 05.08.2022 published: Print CommentOn: Aliment Pharmacol Ther. 2022 May;55(10):1244-1264. - PMID 35355306 Citation Status MEDLINE |
|---|
| doi: |
10.1111/apt.16976 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM342109715 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM342109715 | ||
| 003 | DE-627 | ||
| 005 | 20231226013329.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/apt.16976 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1140.xml |
| 035 | |a (DE-627)NLM342109715 | ||
| 035 | |a (NLM)35689313 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bhurwal, Abhishek |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Editorial |b COVID-19 vaccines are safe and effective in patients with inflammatory bowel disease-but many unanswered questions remain. Authors' reply |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.06.2022 | ||
| 500 | |a Date Revised 05.08.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentOn: Aliment Pharmacol Ther. 2022 May;55(10):1244-1264. - PMID 35355306 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Editorial | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a COVID-19 Vaccines |2 NLM | |
| 700 | 1 | |a Mutneja, Hemant |e verfasserin |4 aut | |
| 700 | 1 | |a Seril, Darren |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Alimentary pharmacology & therapeutics |d 1992 |g 56(2022), 1 vom: 13. Juli, Seite 164-165 |w (DE-627)NLM012692506 |x 1365-2036 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2022 |g number:1 |g day:13 |g month:07 |g pages:164-165 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/apt.16976 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2022 |e 1 |b 13 |c 07 |h 164-165 | ||